Update on Medicare payment policy for treatments involving bamlanivimab
Medicare no longer will pay healthcare providers for administering the COVID-19 treatment bamlanivimab now that the FDA has revoked the Emergency Use Authorization for treatments in which the drug is administered alone.
CMMI announces Direct Contracting participants but cancels second round of applications
The Center for Medicare & Medicaid Innovation announced the 53 entities that have been accepted as participants in the new Global and Professional Direct Contracting model.
HHS delays implementation of rule requiring FQHCs to provide insulin, epinephrine at 340B prices
HHS has postponed a Trump administration regulation that would require federally qualified health centers to make certain drugs more affordable for low-income patients and will consider whether to withdraw the rule altogether.
Disproportionate Share Hospital funding to states doesn’t match up with key benchmarks, report finds
Disproportionate Share Hospital payments don’t always align with key metrics such as uninsured rates and uncompensated care costs, a new policy report finds.
RAND report finds regulating hospital prices would be the most effective way to reduce healthcare spending, but are the proposals viable?
The American Hospital Association had a negative reaction to study findings showing that regulation of hospital prices would be the most effective way to reduce prices paid by commercial insurers.
Hospital groups ask Supreme Court to reverse payment cuts to 340B hospitals, off-campus provider-based departments
The American Hospital Association and other hospital groups are challenging 2020 appeals court decisions that allow HHS to continue slashing payments to 340B hospitals and to off-campus provider-based departments.
Biden’s order to reopen the ACA marketplaces next month draws praise from hospitals
An executive order by President Joe Biden directed HHS to open the Affordable Care Act marketplaces for three months starting in mid-February.
Employers seek shelter from healthcare cost increases in public option
If plans and providers can’t collaborate to control healthcare cost, employers will look to the government to do so.
Post-election Washington policy outlook on health policy priorities
HFMA's Chad Mulvany speculates on health policy priorities and changes in the next 24 months, assuming we continue to have a divided government and President-elect Biden's campaign survives President Trump's many legal challenges about state vote counts.
Analysis: Providers should prepare for reductions in Medicare and Medicaid spending as federal deficit swells
Given the role both Medicare and Medicaid spending play in current and projected federal deficits, spending on both will eventually need to be reduced.